Timothy Lin, MD, MBA
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Timothy Lin
Dr. Timothy Lin is an Assistant Professor in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Before his appointment as faculty, he received his MD from Baylor College of Medicine, followed by completion of radiation oncology residency at Johns Hopkins Hospital in Baltimore, MD, where he served as chief resident.
In his clinical practice, Dr. Lin specializes in the treatment of patients with hematologic malignancies with radiation therapy. In addition to clinical investigation aimed at improving the delivery of radiation therapy for patients with hematologic malignancies, Dr. Lin conducts research into clinical trial design, including the use of patient-centered methods to evaluate treatment effectiveness and statistical approaches that enhance trial efficiency and interpretability. His research has been presented at international conferences and published in several leading peer-reviewed medical journals.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Radiation Oncology Department, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2019 | Baylor College of Medicine, Houston, TX, US, MD |
| 2019 | Jones Graduate School of Business, Rice University, Houston, TX, US, MBA |
| 2014 | Washington University in St. Louis, St. Louis, MO, US, Biology & Anthropology, BA |
Postgraduate Training
| 2023-2024 | Chief Resident, Johns Hopkins Hospital, Baltimore, MD |
| 2020-2024 | Clinical Residency, Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD |
| 2019-2020 | Clinical Internship, Preliminary Medicine, John Hopkins Hospital, Baltimore, MD |
Experience & Service
Institutional Committee Activities
Committee Member, ASTRO Congressional Relations Sub-Committee, 2023 - Present
Committee Member, ASTRO Payer Relations Sub-Committee, 2023 - Present
Representative, Johns Hopkins Residency Housestaff Council, 2021 - 2022
Honors & Awards
| 2024 | Roentgen Resident Research Award, Johns Hopkins Hospital |
| 2023 | American Radium Society Travel Grant Recipient, Johns Hopkins Hospital |
| 2022 | ASCO Conquer Cancer Merit Award Recipient, Johns Hopkins Hospital |
| 2018 | Radiological Society of North American Travel Award, Baylor College of Medicince |
| 2018 | Chinese American Physician's Society Scholarship, Baylor College of Medicine |
| 2018 | Chinese American Doctors Association of Houston Scholarship, Baylor College of Medicine |
| 2017 | T. Jay Collins Full Tuition Merit Scholarship, Jones Graduate School of Business, Rice University |
| 2014 | Magna Cum Laude, Washington University in St. Louis |
| 2010 | National Merit Scholarship, Washington University in St. Louis |
| 2010 | Auxiliary to Texas Children's Hospital, Scholarship, Washington University in St. Louis |
| 2010 | Suzy Mercado Scholarship Foundation, 4-Year Scholarship, Washington University in St. Louis |
| 2010 | American Chemical Society, Scholarship, Washington University in St. Louis |
| 2009 | Eagle Scout Award, The Boy Scouts of America |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Lin TA, Paul N, Luu H, Cheung D, Saberi B, Ottmann S, Gurakar A, Yarchoan M, Narang A, Kim A, Meyer JJ. Patterns and kinetics of hepatocellular carcinoma relapse post-liver transplantation: oligorecurrence and role of local therapies. J Gastrointest Oncol 14(6):2466-2478, 2023. e-Pub 2023. PMID: 38196532.
- Wong SC, Reddy AV, Hacker-Prietz A, Kress L, Pathak P, Hill CS, Lin TA, Herman JM, He J, Zheng L, Brown M, Narang AK. Effectiveness of the nutrition referral system in a multidisciplinary pancreatic cancer clinic. Support Care Cancer 31(6), 2023. e-Pub 2023. PMID: 37148382.
- Lin T, Reddy A, Hill C, Sehgal S, He J, Zheng L, Herman J, Meyer J, Narang A. The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer. Cancers (Basel) 15(4):1252, 2023. e-Pub 2023. PMID: 36831594.
- Lin JS, Muhammad H, Lin TA, Kamel I, Baghdadi A, Rizkalla N, Ottmann SE, Wesson R, Philosophe B, Gurakar A. Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report. Transplant Direct 9(2):1431, 2023. e-Pub 2023. PMID: 36700065.
Other Articles
- Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Abi Jaoude J, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas CR Jr, Koay EJ, Tang C, Msaouel P, Ludmir EB Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials. Int J Radiat Oncol Biol Phys, 2024. PMID: 39352322.
- Lin TA, McCaw ZR, Koong A, Lin C, Jaoude JA, Patel R, Kouzy R, El Alam MB, Sherry AD, Noticewala SS, Fuller CD, Thomas CR, Sun R, Lee J, Lin R, Yuan Y, Shyr Y, Meirson T, Ludmir EB Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation. Clin Cancer Res, 2024.
- Sherry AD, Msaouel P, Kupferman GS, Lin TA, Abi Jaoude J, Kouzy R, McCaw ZR, Ludmir EB, van Zwet Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology. JCO Precis Oncol, 2024. PMID: 39348660.
- Sherry AD, Passy AH, McCaw ZR, Jaoude JA, Lin TA, Kouzy R, Miller AM, Kupferman GS, Beck EJ, Msaouel P, Ludmir EB Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. JCO Clin Cancer Inform, 2024. PMID: 39213473.
- Beck EJ, Sherry AD, Florez MA, Kouzy R, Abi Jaoude J, Lin TA, Miller AM, Passy AH, Kupferman GS, Patel RR, Chino F, Higbie VS, Parseghian CM, Overman MJ, Minsky BD, Thomas CR Jr, Tang C, Msaouel P, Ludmir EB Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer Res Commun, 2024. PMID: 39099199.
- Sherry AD, Lin TA, McCaw ZR, Ludmir EB Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding "Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3" by M. P. Goetz et al. Ann Oncol, 2024. PMID: 38838846.
- Sherry AD, Msaouel P, Kouzy R, Jaoude JA, Lin TA, Taniguchi CM, Fuller CD, Minsky B, Ludmir EB Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. Oncologist, 2024. PMID: 38824414.
- Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Jaoude JA, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee J, Meirson T, Ludmir EB Informative censoring is associated with overall survival in phase 3 oncology clinical trials. J Natl Cancer Inst, 2024. PMID: 38331394.
- Lin TA, Song DY European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy. Transl Androl Urol 13(4):622-625, 2024. PMID: 38721294.
- Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Jaoude JA, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas Jr CR, Koay EJ, Tang C, Msaouel P, Ludmir EB Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials. Int J Cancer, 2024.
- Sherry AD, Msaouel P, McCaw ZR, Jaoude JA, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy Author links open overlay panel. Eur J Cancer, 2023. PMID: 37827064.
- Lin TA, Sherry AD, Ludmir EB Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials. Semin Radiat Oncol, 2023. PMID: 37684072.
- Lin TA, Narang A The Role of Radiotherapy in Metastatic Pancreatic Cancer: A Narrative Review. Digestive Medicine Research 6, 2023.
- Lin TA, Narang A Advances in Radiotherapy for Rectal Cancer. Surg Oncol Clin N Am 32(3):461-473, 2023. PMID: 37182987.
- Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee J, Kupferman M, Raghav KP, Overman MJ, Thomas Jr CR, Ludmir EB Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. JAMA Netw Open, 2023. PMID: 37195664.
- Lin TA, Wei L, Ludmir EB Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma. JAMA, 2023. PMID: 36648473.
- Das A, Lin TA, Lin C, Meirson T, McCaw ZR, Tian L, Ludmir EB Assessment of Median and Mean Survival Time in Cancer Clinical Trials. JAMA Netw Open, 2023. PMID: 37010873.
- Lin TA, Das A, McCaw Z, Ludmir EB Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma. J Clin Oncol, 2023. PMID: 37015029.
- Patel RR, Parisi R, Verma V, Kouzy R, Jaoude JA, Lin TA, Fuller CD, VanderWalde NA, Jagsi R, Smith BD, Guadagnolo BA, Thomas Jr CR, Ludmir EB Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers (Basel), 2022. PMID: 35205795.
- Jaoude JA, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller C, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM Food and Drug Administration approvals in phase 3 Cancer clinical trials. BMC Cancer, 2021. PMID: 34118915.
- Elhalawani H, Cardenas CE, Volpe S, Barua S, Stieb S, Rock CB, Lin TA, Yang P, Wu H, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, R Mohamed AS, Court LE, Hutcheson KA, Gunn G, Rosenthal DI, Frank SJ, Garden AS, Rao A, Fuller CD 18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer. Clin Transl Radiat Oncol, 2021. PMID: 34195391.
- Pasalic D, Fuller C, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas Jr CR, Minsky BD, Ludmir EB Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clin Proc, 2021. PMID: 33549260.
- Kouzy R, Jaoude JA, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB Professional Medical Writer Assistance in Oncology Clinical Trials. Oncologist, 2020. PMID: 32885898.
- Lin TA, Ludmir EB, Liao K, McAleer MF, Bishop AJ, Grosshans D, McGovern S, Woodhouse KD, Paulino AC, Yeboa DN Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer, 2020. PMID: 32881378.
- Jaoude JA, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller C, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB Performance Status Restriction in Phase III Cancer Clinical Trials. J Natl Compr Canc Netw, 2020. PMID: 33022640.
- Jaoude JA, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA Exclusion of Older Adults in COVID-19 Clinical Trials. Mayo Clin Proc, 2020. PMID: 33012364.
- Elhalawani H, R Mohamed AS, Elgohari B, Lin TA, Sikora AG, Lai SY, Abusaif A, Phan J, Morrison WH, Gunn G, Rosenthal DI, Garden AS, Fuller CD, Sandulache VC Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer, 2020. PMID: 32967643.
- Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas Jr CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers (Basel), 2020. PMID: 32947844.
- Pasalic D, McGinnis GJ, Fuller C, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas Jr CR, Minsky BD, Ludmir EB Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer, 2020. PMID: 32702645.
- Grant SR, Lin TA, Miller AB, Mainwaring W, Espinoza AF, Jethanandani A, Walker GV, Smith BD, Guadagnolo B, Jagsi R, Fuller C, Thomas Jr CR, Ludmir EB Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials. JNCI Cancer Spectr, 2020. PMID: 33225207.
- Grant SR, Noticewala SS, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Gunn GB, Fuller CD, Thomas Jr CR, Portelance L, Ludmir EB Non-English language validation of patient-reported outcome measures in cancer clinical trials. Support Care Cancer, 2020. PMID: 32189098.
- Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist, 2020. PMID: 32272505.
- Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller C, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB Exclusion of patients with brain metastases from cancer clinical trials. Neuro Oncol, 2020. PMID: 31900480.
- Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P Reporting and exclusion of sexual and gender minorities in cancer clinical trials. Int J Cancer, 2020. PMID: 31584188.
- Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P Incidence and correlates of HIV exclusion criteria in cancer clinical trials. Int J Cancer, 2020. PMID: 31746465.
- Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas Jr CR, Fuller CD, VanderWalde NA Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol, 2020. PMID: 31711757.
- Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E Sex-Based Disparities Among Cancer Clinical Trial Participants. J Natl Cancer Inst, 2020. PMID: 31350545.
- Heukelom J, Kantor ME, R Mohamed AS, Elhalawani H, Kocak-Uzel E, Lin TA, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke J Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation. Radiother Oncol, 2020. PMID: 31431381.
- Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology. J Natl Cancer Inst, 2019. PMID: 31165160.
- Ludmir EB, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Holliday EB Women's Representation Among Lead Investigators of Clinical Trials in Oncology. JAMA Oncol, 2019. PMID: 31393530.
- Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas Jr CR, Fuller CD Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. JAMA Oncol, 2019. PMID: 31158272.
- Lin TA, Garden AS, Elhalawani H, Elgohari B, Jethanandani A, Ng SP, Mohamed AS, Frank SJ, Glisson BS, Debnam JM, Sturgis EM, Phan J, Reddy JP, Fuller CD, Morrison WH, Skinner HD, Rosenthal DI, Gunn GB Radiographic Retropharyngeal Lymph Node Involvement in Human Papillomavirus-Associated Oropharyngeal Carcinoma: Patterns of Involvement and Impact on Patient Outcomes. Cancer, 2019. PMID: 30620385.
- Elhalawani H, Elgohari B, Lin TA, R Mohamed AS, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, B Spoelstra FO, Gaspar LE, Kachnic LA, Thomas Jr CR, Okunieff P, Fuller CD An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. Clin Transl Radiat Oncol, 2019. PMID: 30775563.
- Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Grossberg AJ, Fuller C Assessing the Impact of Complementary and Alternative Medicine Trials in Oncology. Integr Cancer Ther, 2019. PMID: 31220950.
- Lin TA, Lin JS, Wagner T, Pham N Stereotactic Body Radiation Therapy in Primary Hepatocellular Carcinoma: Current Status and Future Directions. J Gastrointest Oncol, 2018. PMID: 30505586.
- Elhalawani H, Lin TA, Volpe S, R Mohamed AS, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai G, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD Machine Learning Applications in Head and Neck Radiation Oncology: Lessons from Open-Source Radiomics Challenges. Front Oncol, 2018. PMID: 30175071.
- Jethanandani A, Lin TA, Volpe S, Elhalawani H, R Mohamed AS, Yang P, Fuller CD Exploring Applications of Radiomics in Magnetic Resonance Imaging of Head and Neck Cancer: A Systematic Review. Front Oncol, 2018. PMID: 29868465.
- Lin TA, Ludmir EB, Liao K, McAleer MF, Grosshans DR, McGovern SL, Bishop AJ, Woodhouse KD, Paulino AC, Yeboa DN Timing of Local Therapy Impacts Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys, 2018. PMID: 30593906.
Book Chapters
- Lin TA, Yan J, Redmond KJ. Glomus Tumors. In: Adult CNS Radiation Oncology: Principles and Practices. 1. Springer, 2018.
- Chen E, Lin TA. Intraocular Foreign Body. In: Essential Evidence Plus.
Selected Presentations & Talks
Local Presentations
- 2025. Case-based Learning on Non-Hodgkin/Hodgkin Lymphoma. Invited. Tilman J. Fertitta Family College of Medicine - University of Houston. Houston, Texas, US.
National Presentations
- 2023. Visceral Artery Pseudoaneurysm Rates After Pancreatoduodenectomy in Patients Who Received Pre- operative Radiation For Pancreatic Cancer. Poster. 2023 American Society of Radiation Oncology Annual Meeting. San Diego, CA, US.
- 2023. Low Dose Fractionated Radiation Therapy As a Chemo-Potentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase I/II Trial. Conference. 2023 American Society for Radiation Oncology Annual Meeting. San Diego, CA, US.
- 2023. Systematic review of local time-to-event endpoints in pancreatic cancer trials involving radiotherapy. Poster. 2023 American Society of Radiation Oncology Annual Meeting. San Diego, CA, US.
- 2023. Patterns of failure in hepatocellular carcinoma after liver transplantation, and impact of local therapy on post-recurrence outcomes. Poster. 2023 American Society of Radiation Oncology Annual Meeting. San Diego, SA, US.
- 2023. Pathway mutations are associated with clinical outcomes in localized pancreatic cancer treated with neoadjuvant chemoradiation followed by surgery. Poster. 2023 American Society of Radiation Oncology Annual Meeting. San Diego, CA, US.
- 2023. Characterization of DNA Damage Response- Associated Somatic Mutations in Borderline Resectable and Locally Advanced Pancreatic Cancer. Poster. 2023 American Society of Radiation Oncology Annual Meeting. San Diego, CA, US.
- 2022. The Optimal Timing of Surgery Following Stereotactic Body Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer. Poster. 2022 American Society of Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2022. Incidence and impact of proportional hazards violations in phase 3 cancer clinical trials. Poster. 2022 American Society of Clinical Oncology Annual Meeting. Chicago, IL, US.
- 2021. Utility of Short Initial MRI Brain in Brain Metastases Patients Treated With Stereotactic Radiosurgery. Poster. 2021 American Society of Radiation Oncology Annual Meeting. Chicago, IL, US.
- 2021. Utility of Short Initial MRI Brain in Brain Metastases Patients Treated With Stereotactic Radiosurgery. Exploring the optimal timing of routine initial surveillance MRI following treatment of brain metastases with stereotactic radiosurgery: a comparison of two approaches. Poster. The Society for Neuro-Oncology Third Annual Conference on Brain Metastases 2021, Virtual, US.
- 2021. Impact of NOTCH mutational status and neoadjuvant therapy on outcomes in patients with borderline resectable/locally advanced pancreatic cancer. Conference. 2023 American Radium Society Annual Meeting. Lahaina, HI, US.
- 2018. Low-Lying Lymph Node (LLLN) Involvement in Human Papillomavirus (HPV)-associated Oropharyngeal Carcinoma (OPC). Conference. 2018 Radiological Society of North America Annual Conference. Chicago, IL, US.
- 2018. The difference between planned and delivered dose for head and neck cancer, and the consequences for normal tissue toxicity probability. Poster. 2018 American Society of Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2018. FDG-PET Imaging-derived Radiomics Correlates of Human Papilloma Virus status: Connecting the Dots in the Oropharyngeal Cancer Biology, Metabolism, and Imaging Interplay. Poster. 2018 American Society of Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2018. Investigating Semi-Quantitative in-vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures following chemoradiation in the IMRT Era. Poster. 2018 American Society for Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2018. Retropharyngeal Lymph Node Involvement in Human Papillomavirus (HPV)-associated Oropharyngeal Cancer (OPC). Poster. 2018 American Society of Radiation Oncology Annual Meeting. San Antonio, TX, US.
- 2018. Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma. Poster. University of Texas Medical Branch 59th Annual National Student Research Forum. Galveston, TX, US.
- 2018. HPV Status in Oropharyngeal Cancer Patients: A Correlation between Tumor Biology and Metabolic Imaging Parameters. Poster. American College of Physicians Internal Medicine Meeting. New Orleans, LA, US.
- 2018. P16 and HPV-DNA Tests Discordance in Human Papilloma Virus (HPV)-associated Oropharyngeal Cancer: Results from a Case- matched Study. Poster. 2018 Multidisciplinary Head and Neck Cancers Symposium. Scottsdale, AZ, US.
- 2017. HPV Discordance in Recurrent Oropharyngeal Cancer. Poster. 2017 American College of Physicians Tennessee Chapter Meeting. Franklin, TN, US.
- 2017. I Smell a Rat: An Unrecognized Cause of Fever, Leukocytosis, and Transaminitis. Poster. Society of Hospital Medicine National Conference. Las Vegas, NV, US.
Patient Reviews
CV information above last modified March 24, 2025